MK (Downer) Rehnquist is a seasoned professional in the field of real-world data and oncology, currently serving as the Director of Real World Evidence at Gilead Sciences since June 2022. Rehnquist has received notable accolades, including the Key Contributor Grant Recipient and "Outstanding Performance" award in 2023. Prior experience includes multiple roles at Genentech, where significant contributions as a Senior Data Scientist were acknowledged with "Exceptional Performance" awards in 2021 and 2019, along with earlier positions as a Data Scientist and Associate Data Scientist. Academic credentials include a PhD in Epidemiology from Harvard University and a Master of Science in Nutritional Epidemiology, complemented by various research assistant roles and teaching experience throughout academic tenure. Rehnquist's educational background began with a Bachelor of Arts in Psychology from Boston College.
This person is not in any teams
This person is not in any offices